Publication | Open Access

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial

Ii TrialRadiation MedicineRadiation TherapySquamous Cell CarcinomaMedicineHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyNeck UnfitRadiologyHealth Sciences